Clinical Trial Update: A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating JNJ-87189401 in combination with JNJ-78278343 for advanced prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• JNJ-78278343
• JNJ-87189401

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Advanced Prostate Cancer | Phase 1 | Status: RECRUITING